Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07290244RecruitingPhase 1
Testing ER-100 safety for glaucoma or NAION patients
This trial tests whether a new drug, ER-100, is safe for people with glaucoma or a sudden optic nerve injury called NAION. It aims to see if the drug can be given without serious side effects.
Glendale, CaliforniaAges 40–85 - NCT07291973Recruiting
Microwave ablation for small lung tumors
This study tests a new microwave device that uses heat to destroy small lung tumors. It may be an option if your nodule is 20 mm or smaller and cannot be removed with surgery.
ParisAges 18 years+ - NCT07289763RecruitingPhase 2
Study of SHR-2173 for primary membranous nephropathy
This trial tests an investigational drug called SHR-2173 for people with primary membranous nephropathy, a kidney disease that causes protein leakage. The study aims to see if the drug is safe and effective, and it involves periodic injections and monitoring.
Nanjing, JiangsuAges 18–75 - NCT07292714RecruitingPhase 2
Testing 9MW1911 for people with moderate to severe COPD
This trial tests a new medication called 9MW1911 to see if it can help people with moderate to severe COPD who have had recent flare-ups. It is for current or former smokers ages 40 to 75 who are already on standard COPD treatments.
Chizhou, AnhuiAges 40–75 - NCT07294976Recruiting
Testing maximum gain in bone-anchored hearing devices
This trial tests the maximum sound gain you can get from your bone-anchored hearing device. If you already use an Oticon Medical compatible system and have mixed hearing loss, this study will check how well your device performs.
GothenburgAges 18 years+ - NCT07288333RecruitingPhase 2
New medication for schizophrenia in hospitalized adults
This study tests an experimental medication (NBI-1117570) for adults with schizophrenia who are currently in the hospital because of a sudden worsening of symptoms. The goal is to see if this new treatment can help control symptoms better.
KazanlakAges 18–55 - NCT07295717RecruitingPhase 1
ALN-4285 safety study in healthy adults
This study tests a new medicine called ALN-4285 in healthy adults to see how safe it is and how the body processes it. It may help find a new treatment for certain conditions.
LondonAges 18–65 - NCT07289477RecruitingPhase 1
Study of NouvNeu001 for Multiple System Atrophy
This study tests a new injection called NouvNeu001 for people with Multiple System Atrophy (MSA). The goal is to see if it can help control symptoms that standard treatments aren't managing well.
Beijing, Beijing MunicipalityAges 30–70 - NCT07291076RecruitingPhase 1/Phase 2
Study of Pumitamig with Ipilimumab for first-line advanced liver cancer
This trial tests a new drug called pumitamig, either alone or with another drug (ipilimumab), for people with advanced liver cancer that hasn't been treated yet. The goal is to see if these drugs can help shrink or control the cancer.
Duarte, CaliforniaAges 18 years+ - NCT07293351RecruitingPhase 1/Phase 2
Pumitamig alone or with other drugs for advanced kidney cancer
This study tests a new drug called pumitamig, given alone or with other treatments, for people with advanced kidney cancer that has spread or cannot be removed. It aims to see if the drug is safe and if it helps shrink tumors.
Palo Alto, CaliforniaAges 18 years+ - NCT07294508RecruitingPhase 2/Phase 3
Testing a new drug combo for HER2-positive advanced breast cancer
This trial tests two study drugs, HLX22 and HLX87, together for people with HER2-positive breast cancer that has spread or come back. It may be an option if you haven't yet had chemotherapy or HER2-targeted therapy for advanced disease.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07293117Recruiting
Testing Lifeblood supplement for iron and energy
This study tests a dietary supplement called Heart & Soil's Lifeblood to see if it can help improve your iron levels and energy. It might be a good fit if you're an average adult without certain health conditions.
New York, New YorkAges 18 years+ - NCT07288567RecruitingPhase 3
KarXT for teens with schizophrenia
This trial tests if a new medicine, KarXT, can safely and effectively treat schizophrenia in adolescents. It may help teenagers who have active symptoms like hallucinations or disorganized thinking.
Anaheim, CaliforniaAges 13–17 - NCT06880575Recruiting
Registry for seniors with coronary heart disease (SILVER-China)
This registry study in China is following older adults (75+) with coronary heart disease to learn more about their health over time. It involves sharing your medical information and coming back for check-ups, but no experimental treatments are given.
Beijing, Beijing MunicipalityAges 75 years+ - NCT05191264Recruiting
Screws plus cement to treat bone metastases
This trial looks at a treatment that uses metal screws along with cement to stabilize and treat weakening spots in bones caused by metastases. It’s meant for people who have already received this type of procedure and want to be included in the study.
Saint-EtienneAges 18 years+ - NCT06186973Recruiting
Fetal and newborn heart assessment during labor
This study checks how well a baby's heart works during labor and right after birth. It uses a special monitor (CTG with STAN) to see if the baby's heart responds normally to the stress of labor.
OsloAges birth–1 hour - NCT06453512Recruiting
Testing Doublebase Once Moisturizer for Atopic Eczema
This study tests a moisturizer called Doublebase Once for people with atopic eczema. You apply it once a day for 4 weeks to see how well it improves skin moisture and eczema symptoms.
Nottingham, NottinghamshireAges Any age - NCT06757244RecruitingPhase 2
Dovipa: Immunotherapy and vitamin D with chemo for advanced pancreatic cancer
This trial tests whether combining the immunotherapy dostarlimab with vitamin D3 and standard chemotherapy (mFOLFIRINOX) can help people with stage IV pancreatic cancer. It aims to see if this new approach is safe and effective.
MarseilleAges 18–75 - NCT06881745Recruiting
Lifestyle and nutrition study for active adults
This study evaluates the lifestyle and nutrition habits of physically active people and athletes to understand how these factors affect health and performance.
Pavia, PVAges 18–65 - NCT04700878Recruiting
Compassion course study for healthcare workers under stress
This trial tests whether a digital “compassion” training course can reduce stress in people who work directly with patients. You may be offered the course (or not, depending on random assignment) to see if it improves how you feel at work.
Vaxjo, Kronoberg CountyAges 20 years+ - NCT06084572Recruiting
Study of pH-impedance tests for GERD diagnosis
This trial looks at how well a special test (pH-impedance) can diagnose GERD (acid reflux disease) when done correctly. It will use a new way to read the test results to see if it helps doctors classify GERD better.
AnderlechtAges 18–80 - NCT06693934Recruiting
Prevention program for young adults at risk of diabetes
This trial offers a prevention program for young adults aged 18 to 44 who have at least one risk factor for diabetes but do not already have diabetes. The program aims to help prevent or delay the onset of diabetes.
Hong KongAges 18–44 - NCT07286032RecruitingPhase 3
Study of a pill to raise low platelets after chemo
This study tests an investigational pill (hetrombopag) to see if it can safely raise platelet counts in people with solid tumors whose platelets drop after chemotherapy. If you are receiving platinum- or gemcitabine-based chemo and have low platelets due to chemo, this trial may be an option.
Long Beach, CaliforniaAges 18 years+ - NCT07282847RecruitingPhase 1/Phase 2
Gene therapy for adults with Pompe disease
This study tests a one-time gene therapy (AB-1009) for adults with late-onset Pompe disease. It aims to see if the treatment is safe and improves muscle and breathing function.
Phoenix, ArizonaAges 18–65
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.